| Product Code: ETC7647374 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s import market for carcinoembryonic antigen in 2024 continued to be dominated by top exporting countries including Switzerland, USA, Germany, China, and Belgium. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a negative compound annual growth rate (CAGR) of -13.88% from 2020 to 2024. However, there was a positive growth rate of 8.63% from 2023 to 2024, suggesting potential shifts in market dynamics and opportunities for both Israeli importers and exporters in the year ahead.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Carcinoembryonic Antigen Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Carcinoembryonic Antigen Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Israel Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Israel Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Israel Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of early cancer screening programs |
4.2.3 Technological advancements in CEA testing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for CEA tests |
4.3.2 High cost associated with CEA testing |
4.3.3 Limited reimbursement policies for CEA tests |
5 Israel Carcinoembryonic Antigen Market Trends |
6 Israel Carcinoembryonic Antigen Market, By Types |
6.1 Israel Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.4 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.1.5 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2022 - 2032F |
6.1.6 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.7 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2022 - 2032F |
6.1.8 Israel Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Israel Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Israel Carcinoembryonic Antigen Market Imports from Major Countries |
8 Israel Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of CEA testing in Israel |
8.2 Number of new cancer cases detected through CEA testing |
8.3 Investment in research and development for CEA testing technology |
9 Israel Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Israel Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Israel Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Israel Carcinoembryonic Antigen Market Revenue Share, By Companies, 2025 |
10.2 Israel Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here